HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia

Background and purpose: Vascular dementia (VaD) is the second common cause of dementia after Alzheimer’s disease in older people. Yet, there are no FDA approved drugs specifically for VaD. In this study, we have investigated the therapeutic effects of human umbilical cord blood cells (HUCBC) treatme...

Full description

Bibliographic Details
Main Authors: Poornima Venkat, Lauren Culmone, Michael Chopp, Julie Landschoot-Ward, Fengjie Wang, Alex Zacharek, Jieli Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2020.00258/full